Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leronlimab in NASH
NCT04521114Phase 2Completed
- Sponsor
- CytoDyn Inc.
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of leronlimab in Nonalcoholic steatohepatitis (NASH), sponsored by CytoDyn Inc.. Started Dec 2020; status: completed.
02
Drugs
leronlimab
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT04521114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521114.